Physician profile
Wanda C Batson
NPI 1053342253
$4,973.33
in general payments reported to CMS, 2019-2025
17 companies · $463 in 2025
The $463 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,000 · 2020: $197 · 2021: $446 · 2022: $173 · 2023: $148 · 2024: $546 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,093 · Entertainment: $47.22 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.57 |
| Entertainment | $47.22 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,201.29 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $1,088.87 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $362.85 | 2022-2025 | Infuse, Miebo |
| Genentech USA, INC. | $231.00 | 2024 | Vabysmo |
| Alcon Vision LLC | $180.03 | 2019-2024 | Rocklatan |
| Glaukos Corporation | $175.82 | 2020-2022 | |
| Dompe US, INC. | $171.23 | 2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $107.86 | 2023 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $98.47 | 2024 | Catalys System |
| Coopervision INC. | $67.57 | 2021 | |
| Biotissue Holdings INC. | $65.32 | 2025 | |
| Allergan, INC. | $53.01 | 2019-2022 | |
| Optos, INC. | $47.22 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $38.59 | 2025 | Xdemvy |
| Optovue, INC. | $37.40 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $24.44 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $22.36 | 2023 | Clarus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wanda Batson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.